Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Laboratory Corp of America Holdings (LH)

Laboratory Corp of America Holdings (LH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,128,648
  • Shares Outstanding, K 92,700
  • Annual Sales, $ 16,121 M
  • Annual Income, $ 2,377 M
  • 60-Month Beta 1.04
  • Price/Sales 1.43
  • Price/Cash Flow 6.77
  • Price/Book 2.16
Trade LH with:

Options Overview Details

View History
  • Implied Volatility 32.16% ( +0.30%)
  • Historical Volatility 32.71%
  • IV Percentile 83%
  • IV Rank 57.60%
  • IV High 40.37% on 12/03/21
  • IV Low 21.02% on 08/27/21
  • Put/Call Vol Ratio 0.55
  • Today's Volume 17
  • Volume Avg (30-Day) 126
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 5,782
  • Open Int (30-Day) 9,968

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 4.82
  • Number of Estimates 7
  • High Estimate 5.24
  • Low Estimate 4.42
  • Prior Year 6.13
  • Growth Rate Est. (year over year) -21.37%

Price Performance

See More
Period Period Low Period High Performance
1-Month
232.01 +5.94%
on 04/28/22
261.40 -5.98%
on 04/26/22
-18.32 (-6.94%)
since 04/25/22
3-Month
232.01 +5.94%
on 04/28/22
281.22 -12.60%
on 03/22/22
-30.85 (-11.15%)
since 02/25/22
52-Week
232.01 +5.94%
on 04/28/22
317.17 -22.51%
on 12/31/21
-28.67 (-10.45%)
since 05/25/21

Most Recent Stories

More News
3 Diagnostics & Research Stocks to Buy on the Dip

The diagnostics and research industry has witnessed significant growth over the past couple years due to the pandemic-driven tailwinds, growing prevalence of chronic diseases, and rising adoption of advanced...

A : 120.07 (-3.49%)
LH : 246.16 (-1.20%)
WAT : 306.62 (-3.41%)
LabCorp (LH) Introduces Latest Assay for Skin Cancer Patients

LabCorp's (LH) new assay is claimed to have shown a demonstrable clinical advantage in patients suffering from melanoma.

UNH : 494.82 (-0.55%)
LH : 246.16 (-1.20%)
ALKS : 28.84 (+1.73%)
MEDP : 131.62 (-1.28%)
Labcorp Launches New Test for People With Skin Cancer

Finding treatment options for skin cancer may become easier with the launch of a new test by Labcorp (NYSE: LH), a leading global life sciences company. The new test measures Lymphocyte-activation gene...

LH : 246.16 (-1.20%)
Labcorp Receives Emergency Use Authorization for First Non-Prescription At-Home Collection Kit for Combined COVID-19, Flu and RSV Detection

Labcorp (NYSE: LH), a leading global life sciences company, today announced the receipt of Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a combined at-home collection...

LH : 246.16 (-1.20%)
Labcorp to Speak at the UBS 2022 Global Healthcare Conference

Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the UBS 2022 Global Healthcare Conference...

LH : 246.16 (-1.20%)
LabCorp (LH) Debuts At-home Collection Kit for Diabetes Testing

LabCorp's (LH) at-home collection kit makes it effortless for consumers to understand their diabetes risk and health status using an innovative and approved collection device.

UNH : 494.82 (-0.55%)
LH : 246.16 (-1.20%)
ALKS : 28.84 (+1.73%)
MEDP : 131.62 (-1.28%)
Labcorp Launches First-of-its-kind At-home Collection Device for Diabetes Risk Testing

There is a new and convenient way for millions of individuals to assess whether they are at risk for developing diabetes. Labcorp (NYSE: LH), a leading global life sciences company, is making screening...

LH : 246.16 (-1.20%)
Here's Why You Should Retain LabCorp (LH) Stock for Now

Investors are optimistic about LabCorp's (LH) better-than-expected earnings and robust segmental performance.

UNH : 494.82 (-0.55%)
LH : 246.16 (-1.20%)
AMN : 93.72 (+6.34%)
MEDP : 131.62 (-1.28%)
Labcorp Acquires Diagnostic Clinical Laboratory Services From AtlantiCare

Labcorp (NYSE: LH), a leading global life sciences company, and AtlantiCare, the largest health care organization in southern New Jersey, today announced that they have closed a transaction to expand their...

LH : 246.16 (-1.20%)
Labcorp to Webcast Its Annual Meeting of Shareholders

Labcorp (NYSE: LH), a leading global life sciences company, today announced that its Annual Meeting of Shareholders will be webcast live beginning May 11, at 9:00 a.m. ET via the Labcorp Investor Relations...

LH : 246.16 (-1.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients...

See More

Key Turning Points

3rd Resistance Point 256.15
2nd Resistance Point 254.13
1st Resistance Point 251.64
Last Price 246.16
1st Support Level 247.13
2nd Support Level 245.12
3rd Support Level 242.62

See More

52-Week High 317.17
Fibonacci 61.8% 284.64
Fibonacci 50% 274.59
Fibonacci 38.2% 264.54
Last Price 246.16
52-Week Low 232.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar